ArticleThe breast journal2020

A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer.

Takaaki Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.